Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
- Published In:
- Current medicinal chemistry, 19(20), 3301-9 (2012)
- Authors:
- Tateishi, U, Oka, T, Inoue, T
- Database ID:
- RPEP-02088
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02088APA
Tateishi, U; Oka, T; Inoue, T. (2012). Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.. Current medicinal chemistry, 19(20), 3301-9.
MLA
Tateishi, U, et al. "Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.." Current medicinal chemistry, 2012.
RethinkPeptides
RethinkPeptides Research Database. "Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted..." RPEP-02088. Retrieved from https://rethinkpeptides.com/research/tateishi-2012-radiolabeled-rgd-peptides-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.